This trial is designed to compare two different types of arm restrictions for people with CIEDs, in order to improve patient experience and reduce complications.
- Postoperative Complications
1 Primary · 4 Secondary · Reporting Duration: 1 year
2 Treatment Groups
1 of 2
1 of 2
2500 Total Participants · 2 Treatment Groups
Primary Treatment: Lenient Arm · No Placebo Group · Phase 4
Who is running the clinical trial?
Age Any Age · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Has Strict Arm attained the necessary certifications from the Federal Drug Administration?
"Given that this is a Phase 4 trial, which indicates full approval of the treatment, Strict Arm's safety was rated as a 3 on our 1 to 3 scale." - Anonymous Online Contributor
How many participants are enrolled in this trial?
"Affirmative. According to the data hosted on clinicaltrials.gov, this medical trial opened for recruitment on August 19th 2021 and is still looking for participants. 2500 people are needed from a single location to take part in the study." - Anonymous Online Contributor
Is there still room for participation in this clinical investigation?
"Clinicaltrials.gov indicates that this clinical trial is currently open for patient recruitment, with the original posting date being August 19th 2021, and last revision made on September 6th of the same year." - Anonymous Online Contributor